Bezafibrate - ≥98%, high purity , Peroxisome proliferator-activated receptor agonist, CAS No.41859-67-0, Peroxisome proliferator-activated receptor agonist

Item Number

B129520

• Synonyms: bezafibrate|41859-67-0|Bezalip|Cedur|Bezafibrat|Befizal|Bezafibrato|Bezafibratum|Sklerofibrat|Azufibrat|Bezatol|Bezatol SR|Bezafibratum [INN-Latin]|Bezafibrato [INN-Spanish]|BM-15.075|LO 44|Bezatol SR (TN)|BF-759|CCRIS 9085|BM 15075|BM-15075|BM 15.075|2-(
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Bezafibrate is a peroxisome proliferator and hypolipidaemic agent that is a derivative of clofibrate. Shown to be effective in preventing mammary tumors induced by radiation together with DES, possibly by reducing prolactin and triglyceride concentrations
• Storage Temp: Store at 2-8°C
• Shipped In: Wet ice
• Grade: Moligand™
• Action Type: AGONIST
• Mechanism of action: Peroxisome proliferator-activated receptor agonist
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.
A peroxisome proliferator and hypolipidaemic agent.